Summary: This month’s magazine features commentary on determining the ideal patient census and some context for the recent FDA statement on the new anticoagulant, Pradaxa.
Summary: This month’s magazine features commentary on determining the ideal patient census and some context for the recent FDA statement on the new anticoagulant, Pradaxa.